(S,R,S)-AHPC-C4-NH2 (dihydrochloride) is primarily utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis-Targeting Chimeras). This compound acts as a ligand for the von Hippel-Lindau (VHL) E3 ubiquitin ligase, enabling the selective degradation of target proteins within cells. Its application is significant in cancer research, where it is used to degrade oncogenic proteins that are difficult to target with traditional small-molecule inhibitors. Additionally, it serves as a valuable tool in chemical biology for studying protein function and interactions, aiding in the discovery of novel therapeutic strategies for various diseases.